TissueLabs

Private

BellinzonaHealthcare & Life Scienceshttps://www.tissuelabs.com/

Last Round

Pre Seed

Mar 22, 2024

Total Funding Raised

$2.4M

Company Overview

TissueLabs is a biotechnology company that provides a platform for creating tissues and organs in the lab, offering 3D bioprinters, tissue-specific biomaterials, and services.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, 3D Printing, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

3D bioprinterstissue engineeringbiofabrication platformbioprintingorgan printingbiomaterialstissue-specific hydrogelsregenerative medicine3D tissue modelsbioartificial organslab-grown organsdrug discovery3D cell cultureorganoidsanimal testing alternativesbiotech equipmentcell-cultured foodmasked stereolithographyextrusion bioprinting

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TissueLabs Comps

Public and private peers based on sector, stage, and business model.

TissueLabs comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

TissueLabs Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Pre Seed	Mar 22, 2024
Seed	Aug 7, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Gabriel Liguori

Founder And CEO

Founding Team

Felipe chippari

Chief Financial Officer

Executive Team

TissueLabs Investors

Notable investors and investment history

TissueLabs investors
Investor	Rounds
MIT Alumni Angels	Pre Seed
Cietec	Seed
Mergus Ventures	Pre Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Nov 8, 2025
Monthly visitors grew 220% MoM, reaching 5.3K.
Jul 6, 2025
Monthly visitors grew 99% MoM, reaching 1.3K.

View all signals

TissueLabs Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

TissueLabs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TissueLabs's valuation, stock price, and market status.

Firmographic Details

HeadquartersBellinzona

Employee Range16

Year Founded2019

Last FundingMar 22, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.